Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144)

Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144) Publisher Pubmed

Khalighfard S^{1, 2} ; Kalhori MR³ ; Haddad P¹ ; Khori V⁴ ; Alizadeh AM^{2, 5}

Show Affiliations

1. Radiation Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran
2. Breast Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
3. Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
4. Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran
5. Cancer Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: European Journal of Pharmacology Published:2024

Abstract

This article has been retracted at the request of Editor-in-Chief. Fig. 5A has been found to contain identical parts to Fig. 2A of an article published in Oncology Letters (Gu et al., 2015 Oncology Letters 9, 1561, 10.3892/ol.2015.2904). The Editor asked the authors for an explanation but a satisfactory answer was not provided. The Editor-in-Chief concluded that they could not vouch for the validity of the data and have decided to retract the article. © 2024 Elsevier B.V.

Style	Citing Format
MLA	Khalighfard S, et al.. "Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144)." European Journal of Pharmacology, vol. 969, no. , 2024, pp. -.
APA	Khalighfard S, Kalhori MR, Haddad P, Khori V, Alizadeh AM (2024). Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144). European Journal of Pharmacology, 969(), -.
Chicago	Khalighfard S, Kalhori MR, Haddad P, Khori V, Alizadeh AM. "Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144)." European Journal of Pharmacology 969, no. (2024): -.
Harvard	Khalighfard S et al. (2024) 'Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144)', European Journal of Pharmacology, 969(), pp. -.
Vancouver	Khalighfard S, Kalhori MR, Haddad P, Khori V, Alizadeh AM. Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144). European Journal of Pharmacology. 2024;969():-.
BibTex	@article{ author = {Khalighfard S and Kalhori MR and Haddad P and Khori V and Alizadeh AM}, title = {Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144)}, journal = {European Journal of Pharmacology}, volume = {969}, number = {}, pages = {-}, year = {2024} }
RIS	TY - JOUR AU - Khalighfard S AU - Kalhori MR AU - Haddad P AU - Khori V AU - Alizadeh AM TI - Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144) JO - European Journal of Pharmacology VL - 969 IS - SP - EP - PY - 2024 ER -

Style

Citing Format

MLA

Khalighfard S, et al.. "Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144)." European Journal of Pharmacology, vol. 969, no. , 2024, pp. -.

APA

Khalighfard S, Kalhori MR, Haddad P, Khori V, Alizadeh AM (2024). Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144). European Journal of Pharmacology, 969(), -.

Chicago

Khalighfard S, Kalhori MR, Haddad P, Khori V, Alizadeh AM. "Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144)." European Journal of Pharmacology 969, no. (2024): -.

Harvard

Khalighfard S et al. (2024) 'Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144)', European Journal of Pharmacology, 969(), pp. -.

Vancouver

Khalighfard S, Kalhori MR, Haddad P, Khori V, Alizadeh AM. Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144). European Journal of Pharmacology. 2024;969():-.

BibTex

@article{ author = {Khalighfard S and Kalhori MR and Haddad P and Khori V and Alizadeh AM}, title = {Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144)}, journal = {European Journal of Pharmacology}, volume = {969}, number = {}, pages = {-}, year = {2024} }

RIS

TY - JOUR
AU - Khalighfard S
AU - Kalhori MR
AU - Haddad P
AU - Khori V
AU - Alizadeh AM
TI - Retraction Notice to “Enhancement of Resistance to Chemo-Radiation by Hsa-Mir-1290 Expression in Glioblastoma Cells” [Eur. J. Pharmacol. 880 (2020) 173144](S0014299920302363)(10.1016/J.Ejphar.2020.173144)
JO - European Journal of Pharmacology
VL - 969
IS -
SP -
EP -
PY - 2024
ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract